JAK inhibitors in the treatment of adult patients with juvenile idiopathic arthritis: a retrospective monocentric experience

CONCLUSIONS: JAKi may represent an effective and safe treatment option for adult JIA patients with low/moderate disease activity, particularly in case of oligoarticular involvement.PMID:38530666 | DOI:10.55563/clinexprheumatol/4yoas8

Source: Clinical and Experimental Rheumatology - March 26, 2024 Category: Rheumatology Authors: Cecilia B Chighizola Maria Rosa Pellico Marco Pandolfi Luca Marelli Martina Cornalba Irene Pontikaki Stefania Costi Maurizio Gattinara Achille Marino Elisabetta Miserocchi Roberto Caporali Source Type: research